Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany - 18/11/20
, Annelie Plentz b, Anna Sieroslawski c, Fabian Pezenburg a, Michael Pfeifer a, Bernd Salzberger c, Florian Hitzenbichler cAbstract |
Introduction |
The aim of this study was to analyse use of and adherence to influenza and pneumococcal vaccination in high-risk patients with chronic pulmonary disease.
Methods |
The study was initiated at the Centre of Pneumology in Donaustauf, Germany. All patients with asthma bronchiale (AB), chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) that were treated in a pneumological Non-ICU ward, in the sleep laboratory or in the outpatient's clinic between October 1st, 2019 and March 26th, 2020 and provided informed consent were included. Vaccination certificates and a vaccination-centred questionnaire were analysed in relation to vaccination status, risk factors, patient characteristics.
Results |
133 patients with COPD, 68 patients with AB and 104 patients with ILD were included. PCV13/PPSV23 vaccination only (no sequential vaccination) was performed in less than 10%/33% of all patients. Sequential vaccination of PCV13 and PPSV23 was performed in 12.8% of COPD, 7.4% of AB patients and 13.5% of ILD patients.
Influenza vaccination was performed in less than 30% of all patients. Vaccinations were mainly performed by general practitioners (GPs) and rarely by specialists of pulmonary care (<6%). 67% of all patients were seen by a specialist in pulmonary care in the last 36 months, but in less than 15% the vaccination status was evaluated.
Discussion |
Use of and adherence for PPSV23 and influenza vaccinations is low in patients with COPD, AB and ILD in south east Germany.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Adherence to influenza and pneumococcal vaccination is low even in high-risk patients. |
• | Vaccinations are almost exclusively performed by general practitioners. |
• | Side effects are rare in a high-risk population. |
• | Patients are willing to get vaccinated if recommended by the treating physician. |
Keywords : Influenza vaccination, Pneumococcal vaccination, Chronic pulmonary disease
Plan
Vol 174
Article 106207- novembre 2020 Retour au numéro
Article précédent
- Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae
- Ayham Daher, Paul Balfanz, Christian Cornelissen, Annegret Müller, Ingmar Bergs, Nikolaus Marx, Dirk Müller-Wieland, Bojan Hartmann, Michael Dreher, Tobias Müller
- Assessing the need for transfer to the intensive care unit for Coronavirus-19 disease: Epidemiology and risk factors
- Muhammad Daniyal Hashmi, Muhtadi Alnababteh, Karthik Vedantam, Jojo Alunikummannil, Emil S. Oweis, Andrew F. Shorr
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?